실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,268+프로그램
35+FDA 승인
4,079+모집 중
ADC 1068·Antibody 5456·CGT 2744차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
0오늘 방문
738누적 방문
8122갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,162개
다음 갱신 D-10 · 마지막 7월 13일
AntibodystaleImmunityBio, Inc.Phase 3

atezolizumab (Tecentriq, Carboplatin and nab-paclitaxel plus atezolizumab.)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleImmunityBio, Inc.Phase 3

nivolumab (Opdivo, NAI + Nivolumab + Ipilimumab + Carboplatin + Nab-paclitaxel)

Non Small Cell Lung Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleNational Cancer Institute (NCI)Phase 1

aflibercept (Eylea, VEGF Trap-Eye, Eylea HD, Ziv-Aflibercept)

Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Colorectal Carcinoma · FRα

#FR#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleBristol Myers SquibbPhase 3

nivolumab (Opdivo, nivolumab plus relatlimab)

Melanoma, Cutaneous Malignant · Melanoma, Cutaneous Malignant

#MelanomaCutaneousMalignant#Antibody#Phase3#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleHighlight TherapeuticsPhase 2

pembrolizumab (Keytruda, BO-112 with pembrolizumab)

Colorectal Cancer; Gastric Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+3
효능 ORR 0%임상시험 1상태 DISCONTINUED
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab Immunotherapy)

Non-Small Cell Lung Cancer; Non-squamous Non-small-cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleMerckPreclinical

pembrolizumab (Keytruda, pembrolizumab plus axitinib)

Metastatic Renal Cell Carcinoma (mRCC) · Metastatic Renal Cell Carcinoma (mRCC)

#MetastaticRenalCellCarcinomamRCC#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleXijing HospitalPreclinical

Penpulimab combination with anlotinib and chemotherapy (Penpulimab combination with anlotinib and chemotherapy)

Gastric Cancer · Gastric Cancer

#GastricCancer#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodyInstitut BergoniéPhase 2

pembrolizumab (Keytruda, Association of pembrolizumab + cabozantinib)

Soft Tissue Sarcoma Adult; Advanced Soft-tissue Sarcoma · Soft Tissue Sarcoma Adult

#SoftTissueSarcomaAdult#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab alone)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleNational Cancer Centre, Singapo…Phase 2

pembrolizumab (Keytruda, CAPEOX/Pembrolizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleYuan YuanPhase 2

Balstilmab (Balstilmab)

Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Triple-Negative Breast Carcinoma · Anatomic Stage IV Breast Cancer AJCC v8

#AnatomicStageIVBreastCancerAJCCv#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleMerckPhase 2

Phase Ib (Pembrolizumab & ADG106, Pembrolizumab & ADG106 (Phase Ib))

Advanced Solid Tumor; Triple Negative Breast Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleMerckPhase 2

Phase II (Pembrolizumab & ADG106, Pembrolizumab & ADG106 (Phase II))

Advanced Solid Tumor; Triple Negative Breast Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleBristol Myers SquibbPhase 1

nivolumab (Opdivo, Nivolumab Standard)

Metastatic Cancer · Metastatic Cancer

#MetastaticCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleMerckPhase 1

pembrolizumab (Keytruda, Pembrolizumab Standard)

Metastatic Cancer · Metastatic Cancer

#MetastaticCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleBristol Myers SquibbPhase 1

nivolumab (Opdivo, Nivolumab Extended)

Metastatic Cancer · Metastatic Cancer

#MetastaticCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleMerckPhase 1

pembrolizumab (Keytruda, Pembrolizumab Extended)

Metastatic Cancer · Metastatic Cancer

#MetastaticCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodyBiologicstaleMayo ClinicPhase 2

Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine (Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine)

Fallopian Tube Carcinosarcoma; Primary Peritoneal Carcinosarcoma · Fallopian Tube Carcinosarcoma

#FallopianTubeCarcinosarcoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleLinnaeus Therapeutics, Inc.Phase 3

nivolumab and relatlimab (Immunotherapy, Immunotherapy (nivolumab and relatlimab))

Melanoma (Skin Cancer); Melanoma Stage IIIB-IV · Melanoma (Skin Cancer)

#MelanomaSkinCancer#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleLinnaeus Therapeutics, Inc.Phase 3

ipilimumab and nivolumab (Immunotherapy, Immunotherapy (ipilimumab and nivolumab))

Melanoma (Skin Cancer); Melanoma Stage IIIB-IV · Melanoma (Skin Cancer)

#MelanomaSkinCancer#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleMerckPhase 2

anti-PD-1 monoclonal antibody (pembrolizumab, pembrolizumab (anti-PD-1 monoclonal antibody))

Solid Tumor · PD-1

#PD-1#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab + Tamoxifen)

Breast Cancer Female · Breast Cancer Female

#BreastCancerFemale#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab+Carboplatin+albumin-bound paclitaxel:4 courses)

HNSCC; Oral Cancer · PD-1

#PD-1#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleMerckPhase 2

pembrolizumab (Keytruda, Pembrolizumab+Carboplatin+albumin-bound paclitaxel:2 courses)

HNSCC; Oral Cancer · PD-1

#PD-1#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING

89 / 167 페이지

← 이전다음 →
전체 9,268개 프로그램 보기